PPT-Hypoalbuminaemia as a possible biomarker of gastro-intestinal lymphoma in cats

R Lobetti 12 E Lindquist 2 CBerman 1 1 Bryanston Veterinary Hospital Bryanston South Africa 2 SonoPath New Jersey USA Abstract disclosures Authors have no disclosures related to this presentation. IRIA- 1192. Case Discussion. A 46 year old male with complaints of. . -. Dysphagia. x 2 weeks. . -. Epigastric. Pain x 2 weeks. . -Vomiting x 40 hours. An upper gastrointestinal endoscopy was done which revealed a gastro-duodenal junction growth invading the . Common (West), low-grade B-cell lymphoma. Affects elderly. Arises from germinal center B-cell. Lymphoma cells have specific translocation t(14:18), in which Bcl2 gene on chr18 fuses with . IgH. gene on chr14, causing . Worldwide Trends . 2014. What is a Biomarker?. Worldwide Trends. 2014. What is a Biomarker?. A biological marker, better known as a “biomarker”, is a characteristic . that is objectively measured and evaluated as an indicator of normal biological processes, pathogenic processes or pharmacological responses to a therapeutic . Rob Corbett. NCCN. Christchurch. Hodgkin Lymphoma. Great success story!. LMIC. >50% 0-10yrs old. Striking male predominance. Symptoms. 60% < 6months. B symptoms 40%. Wt. loss. Fever. Night sweats. (GIN 2017). . . Dates. . :. . 25th April, 2. nd. May, 8. th. May, 16. th. May. 9.30 am to . 4.30 pm. (exam: 27. th. June 12.30 – 14.30). The Academy, Great Western Hospital, Swindon. . Lauren . Boutwell. MS, RD, LDN. Ming Cheung MS, RD, LDN. Agenda . Lymphoma Overview - L. Nutritional Changes due to Lymphoma - M. Treatment Options - L. Case Study - M. Nutrition Therapy General - L. a closer look . SEER HEMATOPOIETIC DATABASE. Understanding the disease. AMBIGUOUS TERMS. Choosing . the right . Histology & TOPO CODE . Navigation of the Hematopoietic and Lymphoid Neoplasm Database . New . findings and methods for feed engineering to face present and future challenges in salmon . aquaculture. Presenter:. Albert . Caballero Solares, . Ph.D. Collaborators:. X. Xue. 1. , J.R. Hall. 2. Prof Ivy A E . Ekem. 16. th. September 2016. Blood. en.wikipedia.org / M. . Komorniczak. . Accessed 08.09.16. Development of blood cells. en.wikipedia.org. Site of blood formation. www.healthline.com>Ref Library. John Michael Sauer, PhD. Critical Path Institute’s Predictive Safety Testing Consortium. Tucson, Arizona. jsauer@c-path.org. So you have a biomarker(s) that you want to use for regulatory decision making…now what do you do?. Done by:. Shaymaa. Hasan Abbas. Gastro-. oesophageal. . reflux disease. Gastro-. oesophageal. reflux disease (including . non-erosive gastro-. oesophageal. . reflux and erosive . oesophagitis. ) . PhUSE 2014 Paper SP06 Renuka Chinthapally, Cytel Statistical Software & Services Pvt. Ltd., Hyderabad, India ABSTRACT Biomarkers play an important role in the clinical development due to their ability 2 Understanding the biomarker research activity, is critical as multiple stakeholders align themselves with the latest science. CONTENTSFOREWORDBy Edward Abrahams, President, Personalized Medicine Coa infection of the gastrointestinal (or GI) tract. Sometimes people refer to it as “stomach u” although it is not typically caused by the “u” or inuenza virus. This